Abstract: A User Equipment (“UE”) described herein may connect or request connection to a base station of a wireless network. The base station may implement multiple frequency bands, and connecting or requesting connection to the base station may include connecting or requesting connection via a particular frequency band of the multiple frequency bands. The UE may provide an indication of the particular frequency band to a core of the wireless network. The core may select a set of parameters for communications between the UE and the wireless network based on the indication of the particular frequency band. Additionally, or alternatively, the core may provide an indication of the particular frequency band to a device that provides a service to the UE via the wireless network, and the device may select parameters for the service based on the indication of the particular frequency band.

Abstract: A computer device may include a memory storing instructions and processor configured to execute the instructions to receive a session request from an application function (AF) device for a user equipment (UE) device and select a network slice based on the AF device. The computer device may be further configured to send a slice selection trigger to an Access and Mobility Function device for the UE device in response to selecting the network slice, wherein the slice selection trigger includes an instruction to UE device to request the selected network slice; receive a notification from a User Plane Function device associated with the selected slice, wherein the notification identifies a Packet Data Unit session between the UPF device and the UE device; and instruct the AF device to start a session with the UE device via the identified PDU session.

Abstract: A method may include receiving, by at least one network device and from a user device, a registration message including a service identifier and at least one of a network slice identifier or a network slice token. The method may also include determining, based on information included in the registration message, whether the user device is authorized to use a network slice associated with the service identifier. The method may further include setting up a data session to be serviced by the network slice, in response to determining that the user device is authorized to use the network slice.

Abstract: A method, a device, and a non-transitory storage medium are described in which a network slice usage subscription service is provided. The network slice usage subscription service may allow a network device to obtain network slice usage information and event notifications. The event notification may indicate when an end device is using a network slice and when the end device is no longer the network slice. The network device may include an application function (AF) device. The network device may use the event notification to perform an operation relating to the network slice and/or the end device.

Abstract: A system described herein may provide a technique for the predictive determination of regions, such as registration areas associated with a wireless network, with respect to a User Equipment (“UE”) that registers with the wireless network. Such registration areas may be associated with different services, Quality of Service (“QoS”) parameters, network slices, or the like. When registering with the wireless network, the UE may receive an indication of a registration area that includes multiple tracking areas, which include a tracking area in which the UE is currently located and one or more other tracking areas in which the UE is likely to enter, as predicted based on one or more artificial intelligence/machine learning (“AI/ML”) models. The prediction may be based on the current location of the UE, UE attributes or parameters, and/or historical location information associated with the UE and/or other UEs.

Abstract: The invention discloses an online diagnosis method for transformer winding deformation position, including: (1) collecting a transformer with known winding state and decomposing into several position sub-samples; (2) performing feature extraction on each position sub-sample with information entropy, adding with label indicating deformation and inputting into support vector machine to train diagnosis model; (3) decomposing a transformer under diagnosis into 9 position subsamples in the way of step (1), performing feature extraction of step (2) and inputting into the diagnostic model trained in step (2); (4) outputting diagnosis result from the support vector machine about whether the position sub-samples of the transformer is deformed.

Abstract: An adsorbent for halogenated anaesthetics includes: an inorganic material; and an organic material providing a framework for the inorganic material. The inorganic material may be chromium and the organic material may be terephthalic acid. The adsorbent may be formed or configured such that the adsorbent includes coordinatively unsaturated sites or such that the inorganic material may form octahedral structures. The adsorbent is formed or configured to be substantially regenerated at approximately room temperature and to provide selectivity for sevofluorane in water vapour of approximately 1.0. A method of producing an adsorbent includes: selecting an appropriate chemical containing an inorganic material; selecting an organic material to provide a framework for the inorganic material; dissolving the base chemical in water; mixing the organic material with the dissolved base chemical; heating the mixture; filtering the mixture to remove excess organic material; and drying the filtrate.

Abstract: An adsorbent for halogenated anaesthetics includes: an inorganic material; and an organic material providing a framework for the inorganic material. The inorganic material may be chromium and the organic material may be terephthalic acid. The adsorbent may be formed or configured such that the adsorbent includes coordinatively unsaturated sites or such that the inorganic material may form octahedral structures. The adsorbent is formed or configured to be substantially regenerated at approximately room temperature and to provide selectivity for sevofluorane in water vapor of approximately 1.0. A method of producing an adsorbent includes: selecting an appropriate chemical containing an inorganic material; selecting an organic material to provide a framework for the inorganic material; dissolving the base chemical in water; mixing the organic material with the dissolved base chemical; heating the mixture; filtering the mixture to remove excess organic material; and drying the filtrate.

Abstract: Detection of malicious URLs in a Web page retrieved by a computer user is based in a backend security service or upon the user's computer. The HTML code download by the user is first scanned to detect any embedded links such as URLs found in frames or scripts. Features related to the layout of such a URL (position, visibility) are identified. Features related to the referring nature of the URL (page rank of parent, page rank of child) are identified. Features indicating the relevancy between the content of the parent Web page and the content of the Web page identified by the embedded URL identified. Each set of features is transformed into a binary vector and these vectors are fed into a decision engine such as a classifier algorithm. The classifier algorithm outputs a score indicating whether or not the suspect URL (and the Web page to which it links) is malicious or not. The user may be warned by a display message.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Abstract: A boot for a skate has a shoe frame and a shoe sheath. The shoe frame has a heel shank and an insole. The shoe sheath is mounted on the shoe frame and has a sidewall, an internal soft pad and a leather upper cover. The sidewall has an internal chamber. The internal soft pad is made of resilient material and has multiple air vents defined through the internal soft pad. The air vents improve the ventilation of the sidewall to make a sole of a foot inside the sidewall feel comfortable without sweating easily and also keep the sole from becoming unhealthy.

Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picomaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picomaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picomaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picomaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.